Clinical Trial Update: A Study of CT-868 in Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 study of CT-868 in Type 1 Diabetes Mellitus has completed, with overweight and obese participants included in the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 1 Diabetes Mellitus

Drugs mentioned

• CT-868

Snippet

Sponsor: Carmot Therapeutics, Inc. | Conditions: Overweight, Obese | Phase 2 | Status: COMPLETED